Broker maintains Buy on Honasa Consumer; target ₹550 on Mamaearth revival, Derma Co scale-up
Brokerage retains Buy on Honasa Consumer (CMP ₹415.90, TP ₹550), citing Mamaearth's return to growth, Derma Co's scalability and the company's maiden dividend. Models FY26-28E revenue/EBITDA/PAT CAGR of 21/27/23% with FY27/28 EPS revised +2.3/5.8%.
Broker maintains Buy on Honasa Consumer with revised target ₹550, citing Mamaearth's return to growth, Derma Co scalability and maiden dividend. Models 21/27/23% revenue/EBITDA/PAT CAGR over FY26-28E.